Slate Bio Overview

  • Founded
  • 2020
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series 1
  • Latest Deal Amount
  • $1.75M
Latest Deal Amount
  • Investors
  • 5

Slate Bio General Information

Description

Operator of an immunotherapeutics development company based in Charlottesville, Virginia. The company is creating therapies that restore the body's natural immunological response in various diseases using bifunctional IL233 cytokine, thereby providing users with a second independent synergistic pathway that has greater tissue selectivity and improved pharmacodynamics, at lower doses and without side-effects.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 310 2nd Street Southeast
  • Suite B
  • Charlottesville, VA
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Slate Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 19-Jan-2021 $1.75M 00.000 Completed Pre-Clinical Trials
To view Slate Bio’s complete valuation and funding history, request access »

Slate Bio Executive Team (1)

Name Title Board Seat Contact Info
Andrew Krouse Chief Executive Officer, President & Board Member
To view Slate Bio’s complete executive team members history, request access »

Slate Bio Board Members (3)

Name Representing Role Since
Andrew Krouse Slate Bio Chief Executive Officer, President & Board Member 000 0000
Kyparissia Sirinakis Epidarex Capital Board Member 000 0000
Robert Creeden UVA LVG Seed Fund Board Member 000 0000
To view Slate Bio’s complete board members history, request access »

Slate Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Center for Innovative Technology Venture Capital Minority 000 0000 000000 0
Epidarex Capital Venture Capital Minority 000 0000 000000 0
PharmaDirections Corporation Minority 000 0000 000000 0
UVA LVG Seed Fund Venture Capital Minority 000 0000 000000 0
VTC Innovation Fund Venture Capital Minority 000 0000 000000 0
To view Slate Bio’s complete investors history, request access »